MA24626A1 - Compositions parenterales d'alatrofloxacine - Google Patents

Compositions parenterales d'alatrofloxacine

Info

Publication number
MA24626A1
MA24626A1 MA25198A MA25198A MA24626A1 MA 24626 A1 MA24626 A1 MA 24626A1 MA 25198 A MA25198 A MA 25198A MA 25198 A MA25198 A MA 25198A MA 24626 A1 MA24626 A1 MA 24626A1
Authority
MA
Morocco
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
Prior art date
Application number
MA25198A
Other languages
English (en)
Inventor
Robert Mark Guinn
John Francis Lambert
Stanley Walter Walinsky
Subramanian Sam Guhan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA24626A1 publication Critical patent/MA24626A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
MA25198A 1997-08-01 1998-07-31 Compositions parenterales d'alatrofloxacine MA24626A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
MA24626A1 true MA24626A1 (fr) 1999-04-01

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25198A MA24626A1 (fr) 1997-08-01 1998-07-31 Compositions parenterales d'alatrofloxacine

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2387016C (fr) * 1999-10-08 2010-09-28 William H. Miller Utilisation de derives d'acrylamide comme inhibiteurs de fab i
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
WO2003088897A2 (fr) 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
EP1575951B1 (fr) * 2002-12-06 2014-06-25 Debiopharm International SA Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
WO2004082586A2 (fr) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
PL1828167T3 (pl) * 2004-06-04 2015-02-27 Debiopharm Int Sa Pochodne akryloamidu jako środki antybiotykowe
WO2007067416A2 (fr) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Agents therapeutiques et ses procédés de fabrication et d'utilisation
EP2054422B1 (fr) 2006-07-20 2017-06-14 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de fab i
EP3255045A1 (fr) * 2007-02-16 2017-12-13 Debiopharm International SA Sels, promédicaments et polymorphes d'inhibiteurs de fab i
JP6085026B2 (ja) 2012-06-19 2017-02-22 デビオファーム インターナショナル エスエーＤｅｂｉｏｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓａ （ｅ）−ｎ−メチル−ｎ−（（３−メチルベンゾフラン−２−イル）メチル）−３−（７−オキソ−５，６，７，８−テトラヒドロ−１，８−ナフチリジン−３−イル）アクリルアミドのプロドラッグ誘導体
CN106535913B (zh) * 2014-04-25 2021-01-26 诺雷克斯股份有限公司 神经活性肽的稳定组合物
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
CA3176134A1 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions heterodimeres et methodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
RU2147303C1 (ru) 1994-01-18 2000-04-10 Пфайзер Инк. Промежуточные продукты и способ получения солей нафтиридонкарбоновой кислоты
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
EP0789697B1 (fr) 1995-06-06 1998-06-17 Pfizer Inc. FORME DE CRISTAL DE SEL ANHYDRE D'ACIDE METHANE-SULFONIQUE ET D'ACIDE 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTYRIDINE-3 CARBOXYLIQUE
JP3029293B2 (ja) 1995-06-15 2000-04-04 ファイザー・インコーポレーテッド ジペプチドを含む、アザビシクロナフチリジンカルボン酸の誘導体を調製するための方法
DK0847400T3 (da) 1995-08-29 2002-03-25 Pfizer Polymorfer af prolægemidlet 6-N-(L-ALA-L-ALA)-trovafloxacin
JP3188476B2 (ja) 1995-08-29 2001-07-16 ファイザー・インコーポレーテッド 両性イオン形トロバフロキサシン
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
ZA986874B (en) 2000-01-31
HN1998000106A (es) 1999-01-08
DZ2576A1 (fr) 2003-02-22
EA002120B1 (ru) 2001-12-24
DE69821767T2 (de) 2005-01-13
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
NZ502249A (en) 2001-11-30
EA200000086A1 (ru) 2000-08-28
DE69821767D1 (de) 2004-03-25
GT199800112A (es) 2000-01-15
JP2001512133A (ja) 2001-08-21
AP9801310A0 (en) 1998-09-30
KR20010022495A (ko) 2001-03-15
PT1000086E (pt) 2004-05-31
JP3463928B2 (ja) 2003-11-05
AP1031A (en) 2001-12-21
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
HUP0004793A3 (en) 2001-10-29
EP1000086A1 (fr) 2000-05-17
DK1000086T3 (da) 2004-05-17
SK1012000A3 (en) 2000-09-12
ATE259827T1 (de) 2004-03-15
HUP0004793A2 (hu) 2001-04-28
TNSN98146A1 (fr) 2005-03-15
IS5339A (is) 2000-01-14
PE103799A1 (es) 1999-10-25
NO20000485D0 (no) 2000-01-31
HRP980417A2 (en) 1999-08-31
AR015417A1 (es) 2001-05-02
AU734863B2 (en) 2001-06-21
BG104105A (bg) 2000-08-31
CA2296466C (fr) 2003-04-15
YU2500A (sh) 2002-09-19
NO20000485L (no) 2000-03-27
WO1999006430A1 (fr) 1999-02-11
UY25113A1 (es) 2000-12-29
OA11281A (en) 2002-11-19
CA2296466A1 (fr) 1999-02-11
ES2214716T3 (es) 2004-09-16
PA8456701A1 (es) 2000-05-24
CN1265671A (zh) 2000-09-06
EP1000086B1 (fr) 2004-02-18
BR9811580A (pt) 2000-08-22
US6194429B1 (en) 2001-02-27
HRP980417B1 (en) 2002-10-31
ID24374A (id) 2000-07-13
CO4970688A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
ITMI931611A0 (it) Composizione di gasolio
DE69815099D1 (de) Kosmetische zusammensetzungen
DE69616804D1 (de) Wasserdispergierbare copolyester-ether zusammensetzungen
MA24626A1 (fr) Compositions parenterales d'alatrofloxacine
ITMI941407A0 (it) Composizioni cementizie mdf con migliorata tenacita'
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
ID16838A (id) Komposisi dekafluoropentana
IT244003Y1 (it) Tenuta d'albero
EE9800168A (et) Tahked kompositsioonid
ID17419A (id) Komposisi dekafluoropentana
FR2710673B1 (fr) Composition d'enduit de parement.
FR2761461B1 (fr) Etancheite d'une table de cuisson
FR2735986B3 (fr) Prolongateur d'haltere
UA1629S (uk) Набір фестонів "веснянка-5"
UA2139S (uk) Обкладинка телефонного довідника "жовті сторінки"
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
UA1914S (uk) Крекер "фірмовий"
UA2343S (uk) Комплект етикеток "мелітопольська ювілейна "віват"
UA25662A (uk) Аперитив "дебют"
SE9703724D0 (sv) Flexskiva "Flexigrund"
IT243309Y1 (it) Contenitore - espositore per pluralita' di oggetti
UA1498S (uk) Набір етикеток "сумська горобинова"
UA1904S (uk) Набір етикеток "недригайлівська"
UA1499S (uk) Набір етикеток "гусарська"
UA1496S (uk) Набір етикеток "зубровка"